These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 3761308

  • 21. Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes.
    Hjorth S, Clark D, Svensson K, Carlsson A, Thorberg O.
    J Neural Transm; 1985; 64(3-4):187-98. PubMed ID: 3936899
    [Abstract] [Full Text] [Related]

  • 22. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation.
    Hjorth S, Clark D, Carlsson A.
    Eur J Pharmacol; 1988 Aug 02; 152(3):207-15. PubMed ID: 3146512
    [Abstract] [Full Text] [Related]

  • 23. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D, Hjorth S, Carlsson A.
    Eur J Pharmacol; 1984 Oct 30; 106(1):185-9. PubMed ID: 6099268
    [Abstract] [Full Text] [Related]

  • 24. Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations.
    Hjorth S, Clark D, Carlsson A.
    Life Sci; 1985 Aug 19; 37(7):673-84. PubMed ID: 2410756
    [Abstract] [Full Text] [Related]

  • 25. Differential behavioural effects of dopamine agonists in developing rats: a study of 3-PPP enantiomers.
    Arnt J.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):273-8. PubMed ID: 6617748
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. 2,5-Dimethoxy congeners of (+)-and (-)-3-(3-hydroxyphenyl)-N-n- propylpiperidine.
    Cannon JG, Kirschbaum KS, Amoo VE, Johnson AK, Long JP.
    J Med Chem; 1993 Aug 06; 36(16):2416-9. PubMed ID: 8103114
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats.
    Carlsson M, Carlsson A, Eriksson E.
    Eur J Pharmacol; 1987 Oct 06; 142(1):39-43. PubMed ID: 3691635
    [Abstract] [Full Text] [Related]

  • 35. Synthesis and dopamine autoreceptor activity of a 5-(methylmercapto)methyl-substituted derivative of (+/-)-3-PPP (3-(3-hydroxyphenyl)-1-n-propylpiperidine).
    Kelly TR, Howard HR, Koe BK, Sarges R.
    J Med Chem; 1985 Sep 06; 28(9):1368-71. PubMed ID: 3928893
    [Abstract] [Full Text] [Related]

  • 36. Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.
    Mikuni M, Gudelsky GA, Simonovic M, Meltzer HY.
    Life Sci; 1984 Jan 16; 34(3):239-46. PubMed ID: 6694521
    [Abstract] [Full Text] [Related]

  • 37. Carbamate ester derivatives as potential prodrugs of the presynaptic dopamine autoreceptor agonist (-)-3-(3-hydroxyphenyl)-N-propylpiperidine.
    Thorberg SO, Berg S, Lundström J, Pettersson B, Wijkström A, Sanchez D, Lindberg P, Nilsson JL.
    J Med Chem; 1987 Nov 16; 30(11):2008-12. PubMed ID: 3669008
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.